Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial

Khorana, AA; Vadhan-Raj, S; Kuderer, NM; Wun, T; Liebman, H; Soff, G; Belani, C; ... Lyman, GH; + view all Khorana, AA; Vadhan-Raj, S; Kuderer, NM; Wun, T; Liebman, H; Soff, G; Belani, C; O'Reilly, EM; McBane, R; Eikelboom, J; Damaraju, CV; Beyersl, K; Dietrichl, F; Kakkar, AK; Riess, H; Peixoto, RD; Lyman, GH; - view fewer (2017) Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Thrombosis and Haemostasis , 117 (11) pp. 2135-2145. 10.1160/TH17-03-0171 . Green open access

https://ift.tt/2nfQiM6